Disclosures for "Identifying candidate molecular biomarkers in idiopathic intracranial hypertension patients"
-
Dr. Hill has nothing to disclose.
-
Mrs. Begum has nothing to disclose.
-
Miss Hubbard has nothing to disclose.
-
Miss Mugo has nothing to disclose.
-
Dr. Botfield has nothing to disclose.
-
Dr. Lyons has nothing to disclose.
-
Dr. THALLER has nothing to disclose.
-
Dr. Yiangou has nothing to disclose.
-
Dr. Grech has received research support from Sir Jules Thorn.
-
Dr. Mitchell has received personal compensation for serving as an employee of Ministry of Defence.
-
Prof. Mollan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Invex therapeutics. Prof. Mollan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. Prof. Mollan has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Thea pharmaceuticals. The institution of Prof. Mollan has received research support from National Institute of Health Research (UK) .
-
Dr. Sinclair has received personal compensation for serving as an employee of Invex Therapeutics. Dr. Sinclair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Sinclair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Sinclair has stock in Invex Therapeutics. The institution of Dr. Sinclair has received research support from DOD. The institution of Dr. Sinclair has received research support from MOD.